Home
Alto Neuroscience

Alto Neuroscience Market Share Analysis for August 2026

Interested in learning more about our differentiated approach to psychiatry? Get in touch with our team.

Health > Biotechnology and Pharmaceuticals

Domainaltoneuroscience.com

Year Founded2019

Employees51 - 200

Annual Revenue< $1M

Alto Neuroscience

Alto Neuroscience (including company regionals)

altoneuroscience.com

See more website traffic and engagement information

Total visits to Alto Neuroscience's top domains

Understand Alto Neuroscience market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

altoneuroscience.com11.1K

See more with Sales Intelligence

Avg. visit duration in Alto Neuroscience's top domains

Analyze Alto Neuroscience engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

altoneuroscience.com00:00:36

See more with Sales Intelligence

Avg. pageviews on Alto Neuroscience's top domains

See how Alto Neuroscience keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

altoneuroscience.com1.96

See more with Sales Intelligence

Alto Neuroscience top competitors by domain

Top similar sites in August 2026, ranked by their affinity

biohaven.comCompany NameBiohavenEmployees201 - 500HQUnited States, Connecticut, New HavenAnnual revenue--Total visits11.3KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Alto Neuroscience

These are the website technologies, by industry, used by Alto Neuroscience top domains

Content Management System (5)

WordPress

Conversion & Analytics (3)

Google Analytics

Mobile (3)

Meta Viewport

Widget (3)

reCAPTCHA

More Technologies

9

See all

News & Signals from Alto Neuroscience

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlto Neuroscience Inc. promoted Nick Smith to president and chief financial officer on Aug 26th '26.Alto neuroscience promotes nick smith to president and chief financial officer.

NewsAlto Neuroscience, Inc. hired Andrew Miller as Board of Directors on May 27th '26.In another company news, it was reported on May 28 that Alto Neuroscience, Inc. (NYSE:ANRO) announced the appointment of Andrew Miller, Ph.D., to its Board of Directors, effective May 27, 2026.

NewsAlto Neuroscience, Inc. is developing depression drug based on the dopamine agonist pramipexole on Jun 16th '26.Alto Neuroscience is advancing a depression drug based on the dopamine agonist pramipexole, which an independent study has found to help boost feelings of pleasure in patients with mood disorders.